Abstract
In this review, we describe the absorption rates (Caco-2 cell permeability) and hepatic/plasma pharmacokinetics of 53 diverse chemicals estimated by modeling virtual oral administration in rats. To ensure that a broad range of chemical structures is present among the selected substances, the properties described by 196 chemical descriptors in a chemoinformatics tool were calculated for 50,000 randomly selected molecules in the original chemical space. To allow visualization, the resulting chemical space was projected onto a two-dimensional plane using generative topographic mapping. The calculated absorbance rates of the chemicals based on cell permeability studies were found to be inversely correlated to the no-observed-effect levels for hepatoxicity after oral administration, as obtained from the Hazard Evaluation Support System Integrated Platform in Japan (r = −0.88, p < 0.01, n = 27). The maximum plasma concentrations and the areas under the concentration-time curves (AUC) of a varied selection of chemicals were estimated using two different methods: simple one-compartment models (i.e., high-throughput toxicokinetic models) and simplified physiologically based pharmacokinetic (PBPK) modeling consisting of chemical receptor (gut), metabolizing (liver), and central (main) compartments. The results obtained from the two methods were consistent. Although the maximum concentrations and AUC values of the 53 chemicals roughly correlated in the liver and plasma, inconsistencies were apparent between empirically measured concentrations and the PBPK-modeled levels. The lowest-observed-effect levels and the virtual hepatic AUC values obtained using PBPK models were inversely correlated (r = −0.78, p < 0.05, n = 7). The present simplified PBPK models could estimate the relationships between hepatic/plasma concentrations and oral doses of general chemicals using both forward and reverse dosimetry. These methods are therefore valuable for estimating hepatotoxicity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alwis, K.U., Blount, B.C., Britt, A.S., Patel, D. and Ashley, D.L. (2012) Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal. Chim. Acta, 750, 152–160.
Sexton, K., Adgate, J.L., Fredrickson, A.L., Ryan, A.D., Needham, L.L. and Ashley, D.L. (2006) Using biologic markers in blood to assess exposure to multiple environmental chemicals for inner-city children 3–6 years of age. Environ. Health Persp., 114, 453–459.
Bell, S.M., Chang, X., Wambaugh, J.F., Allen, D.G., Bartels, M., Brouwer, K.L.R., Casey, W.M., Choksi, N., Ferguson, S.S., Fraczkiewicz, G., Jarabek, A.M., Ke, A., Lumen, A., Lynn, S.G., Paini, A., Price, P.S., Ring, C., Simon, T.W., Sipes, N.S., Sprankle, C.S., Strickland, J., Troutman, J., Wetmore, B.A. and Kleinstreuer, N.C. (2018) In vitro to in vivo extrapolation for high throughput prioritization and decision making. Toxicol. In Vitro, 47, 213–227.
Rotroff, D.M., Wetmore, B.A., Dix, D.J., Ferguson, S.S., Clewell, H.J., Houck, K.A., LeCluyse, E.L., Andersen, M.E., Judson, R.S., Smith, C.M., Sochaski, M.A., Kavlock, R.J., Boellmann, F., Martin, M.T., Reif, D.M., Wambaugh, J.F. and Thomas, R.S. (2010) Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening. Toxicol. Sci., 117, 348–358.
Wetmore, B.A., Wambaugh, J.F., Ferguson, S.S., Sochaski, M.A., Rotroff, D.M., Freeman, K., Clewell, H.J., III, Dix, D.J., Andersen, M.E., Houck, K.A., Allen, B., Judson, R.S., Singh, R., Kavlock, R.J., Richard, A.M. and Thomas, R.S. (2012) Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol. Sci., 125, 157–174.
Wambaugh, J.F., Wetmore, B.A., Pearce, R., Strope, C., Goldsmith, R., Sluka, J.P., Sedykh, A., Tropsha, A., Bosgra, S., Shah, I., Judson, R., Thomas, R.S. and Setzer, R.W. (2015) Toxicokinetic triage for environmental chemicals. Toxicol. Sci., 147, 55–67.
Wambaugh, J.F., Hughes, M.F., Ring, C.L., MacMillan, D.K., Ford, J., Fennell, T.R., Black, S.R., Snyder, R.W., Sipes, N.S., Wetmore, B., Westerhout, J., Setzer, R.W., Pearce, R., Simmons, J.E. and Thomas, R.S. (2018) Evaluating in vitro-in vivo extrapolation of toxicokinetics. Toxicol. Sci., 63, 152–169.
Takano, R., Murayama, N., Horiuchi, K., Kitajima, M., Kumamoto, M., Shono, F. and Yamazaki, H. (2010) Blood concentrations of acrylonitrile in humans after oral administration extrapolated from in vivo rat pharmacokinetics, in vitro human metabolism, and physiologically based pharmacokinetic modeling. Regul. Toxicol. Pharmacol., 58, 252–258.
Yamazaki, H., Suemizu, H., Mitsui, M., Shimizu, M. and Guengerich, F.P. (2016) Combining chimeric mice with humanized liver, mass spectrometry, and physiologically-based pharmacokinetic modeling in toxicology. Chem. Res. Toxicol., 29, 1903–1911.
Yamashita, S., Tanaka, Y., Endoh, Y., Taki, Y., Sakane, T., Nadai, T. and Sezaki, H. (1997) Analysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo drug absorption. Pharm. Res., 14, 486–491.
Hilgers, A.R., Conradi, R.A. and Burton, P.S. (1990) Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res., 7, 902–910.
Leonard, M., Creed, E., Brayden, D. and Baird, A.W. (2000) Iontophoresis-enhanced absorptive flux of polar molecules across intestinal tissue in vitro. Pharm. Res., 17, 476–478.
Artursson, P., Palm, K. and Luthman, K. (2001) Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev., 46, 27–43.
Neuhoff, S., Ungell, A.L., Zamora, I. and Artursson, P. (2005) pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers. Eur. J. Pharm. Sci., 25, 211–220.
Kamiya, Y., Otsuka, S., Miura, T., Takaku, H., Yamada, R., Nakazato, M., Nakamura, H., Mizuno, S., Shono, F., Funatsu, K. and Yamazaki, H. (2019) Plasma and hepatic concentrations of chemicals after virtual oral administrations extrapolated using rat plasma data and simple physiologically based pharmacokinetic models. Chem. Res. Toxicol., 32, 211–218.
Sakuratani, Y., Zhang, H.Q., Nishikawa, S., Yamazaki, K., Yamada, T., Yamada, J., Gerova, K., Chankov, G., Mekenyan, O. and Hayashi, M. (2013) Hazard Evaluation Support System (HESS) for predicting repeated dose toxicity using toxicological categories. SAR QSAR. Environ. Res., 24, 351–363.
Adachi, K., Suemizu, H., Murayama, N., Shimizu, M. and Yamazaki, H. (2015) Human biofluid concentrations of mono(2-ethylhexyl)phthalate extrapolated from pharmacokinetics in chimeric mice with humanized liver administered with di(2-ethylhexyl)phthalate and physiologically based pharmacokinetic modeling. Environ. Toxicol. Pharmacol., 39, 1067–1073.
Miura, T., Uehara, S., Nakazato, M., Kusama, T., Toda, A., Kamiya, Y., Murayama, N., Shimizu, M., Suemizu, H. and Yamazaki, H. (2019) Human plasma and liver concentrations of styrene estimated by combining a simple physiologically based pharmacokinetic model with rodent data. J. Toxicol. Sci., 44, 543–548.
Miura, T., Suemizu, H., Goto, M., Sakai, N., Iwata, H., Shimizu, M. and Yamazaki, H. (2019) Human urinary concentrations of monoisononyl phthalate estimated using physiologically based pharmacokinetic modeling and experimental pharmacokinetics in humanized-liver mice orally administered with diisononyl phthalate. Xenobiotica, 49, 513–520.
Miura, T., Uehara, S., Mizuno, S., Yoshizawa, M., Murayama, N., Kamiya, Y., Shimizu, M., Suemizu, H. and Yamazaki, H. (2019) Steady-state human pharmacokinetics of monobutyl phthalate predicted by physiologically based pharmacokinetic modeling using single-dose data from humanized-liver mice orally administered with dibutyl phthalate. Chem. Res. Toxicol., 32, 333–340.
Miyaguchi, T., Suemizu, H., Shimizu, M., Shida, S., Nishiyama, S., Takano, R., Murayama, N. and Yamazaki, H. (2015) Human urine and plasma concentrations of bisphenol A extrapolated from pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and semi-physiological pharmacokinetic modeling. Regul. Toxicol. Pharmacol., 72, 71–76.
Shimizu, M. and Yamazaki, H. (2017) Human plasma and urinary metabolic profiles of trimethylamine and trimethylamine N-oxide extrapolated using a simple physiologically based pharmacokinetic model. J. Toxicol. Sci., 42, 485–490.
Shimizu, M., Suemizu, H., Mizuno, S., Kusama, T., Miura, T., Uehara, S. and Yamazaki, H. (2018) Human plasma concentrations of trimethylamine N-oxide extrapolated using pharmacokinetic modeling based on metabolic profiles of deuterium-labeled trimethylamine in humanized-liver mice. J. Toxicol. Sci., 43, 387–393.
Takano, R., Murayama, N., Horiuchi, K., Kitajima, M., Shono, F. and Yamazaki, H. (2010) Blood concentrations of 1,4-dioxane in humans after oral administration extrapolated from in vivo rat pharmacokinetics, in vitro human metabolism, and physiologically based pharmacokinetic modeling. J. Health Sci., 56, 557–565.
Tsukada, A., Suemizu, H., Murayama, N., Takano, R., Shimizu, M., Nakamura, M. and Yamazaki, H. (2013) Plasma concentrations of melengestrol acetate in humans extrapolated from the pharmacokinetics established in in vivo experiments with rats and chimeric mice with humanized liver and physiologically based pharmacokinetic modeling. Regul. Toxicol. Pharmacol., 65, 316–324.
Yamashita, M., Suemizu, H., Murayama, N., Nishiyama, S., Shimizu, M. and Yamazaki, H. (2014) Human plasma concentrations of herbicidal carbamate molinate extrapolated from the pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and physiologically based pharmacokinetic modeling. Regul. Toxicol. Pharmacol., 70, 214–221.
Yamazaki, H., Horiuchi, K., Takano, R., Nagano, T., Shimizu, M., Kitajima, M., Murayama, N. and Shono, F. (2010) Human blood concentrations of cotinine, a biomonitoring marker for tobacco smoke, extrapolated from nicotine metabolism in rats and humans and physiologically based pharmacokinetic modeling. Int. J. Environ. Res. Public Health, 7, 3406–3421.
Yamazaki, H., Takano, R., Horiuchi, K., Shimizu, M., Murayama, N., Kitajima, M. and Shono, F. (2010) Human blood concentrations of dichlorodiphenyltrichloroethane (DDT) extrapolated from metabolism in rats and humans and physiologically based pharmacokinetic modeling. J. Health Sci., 56, 566–575.
Emoto, C., Murayama, N., Rostami-Hodjegan, A. and Yamazaki, H. (2009) Utilization of estimated physicochemical properties as an integrated part of predicting hepatic clearance in the early drug-discovery stage: Impact of plasma and microsomal binding. Xenobiotica, 39, 227–235.
Poulin, P. and Theil, F.P. (2002) Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J. Pharm. Sci., 91, 129–156.
Kato, M., Shitara, Y., Sato, H., Yoshisue, K., Hirano, M., Ikeda, T. and Sugiyama, Y. (2008) The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling. Pharm. Res., 25, 1891–1901.
Yamazaki, H. (2017) Differences in toxicological and pharmacological responses mediated by polymorphic cytochromes P450 and related drug-metabolizing enzymes. Chem. Res. Toxicol., 30, 53–60.
Shimada, T. (2017) Inhibition of carcinogen-activating cytochrome P450 enzymes by xenobiotic chemicals in relation to antimutagenicity and anticarcinogenicity. Toxicol. Res. 33, 79–96.
Nohmi, T. (2018) Thresholds of genotoxic and non-genotoxic carcinogens. Toxicol. Res., 34, 281–90.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Rights and permissions
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Yamazaki, H., Kamiya, Y. Extrapolation of Hepatic Concentrations of Industrial Chemicals Using Pharmacokinetic Models to Predict Hepatotoxicity. Toxicol Res. 35, 295–301 (2019). https://doi.org/10.5487/TR.2019.35.4.295
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2019.35.4.295